Search

everythinglearnresearchcommunity

for

Search:↓

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Laser hair removal is safe and effective for fair-skinned people with dark hair, and using eflornithine with laser treatments can improve results.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Finasteride delivery through skin improved using invasomes and iontophoresis.

A method was created in 2005 to identify minoxidil, a hair growth ingredient, in products using two types of capillary zone electrophoresis, and it found that most products had about 2% minoxidil.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Hair follicles and deer antlers regenerate similarly through stem cells and are influenced by hormones and growth factors.

A boy with a rare form of early puberty caused by a new gene mutation responded well to treatment aimed at reducing testosterone and preserving adult height.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Invasomes effectively deliver drugs through the skin and have potential for improved treatments.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.